YGR164W Antibody

What is YGR164W and why is it important to develop antibodies against it?

YGR164W is a gene locus in Saccharomyces cerevisiae, part of the reference genome derived from laboratory strain S288C . While the search results don't specify the exact function of this gene product, researchers often develop antibodies against yeast proteins to study their localization, interactions, and functions within cellular processes. Antibodies against specific yeast proteins allow researchers to perform various molecular biology techniques such as Western blotting, immunoprecipitation, and chromatin immunoprecipitation (ChIP) to investigate protein expression, modification states, and interactions with other cellular components.

Similar to other yeast protein antibodies like those against Replication Factor A (RFA), YGR164W antibodies would enable researchers to isolate and analyze the protein in various experimental contexts . These antibodies serve as crucial tools for understanding yeast cell biology, which often provides insights relevant to more complex eukaryotic systems, including humans.

What are the optimal methods for validating a YGR164W antibody?

Validation of yeast protein antibodies requires multiple complementary approaches:

• Western blot validation: Test the antibody against wild-type yeast extracts compared to YGR164W deletion strains. An effective antibody should show a specific band of the expected molecular weight in wild-type samples that is absent in deletion strains.

• Specificity testing: Examine cross-reactivity by testing against purified recombinant protein and comparing band patterns in wild-type versus mutant strains at various dilutions (e.g., 1:5000, 1:10,000, 1:20,000) as demonstrated for RFA antibodies .

• Application-specific validation: For each application (Western blot, ChIP, immunoprecipitation), perform specific validation tests. For example, in ChIP applications, verify enrichment at known binding sites compared to control regions.

• Reproducibility assessment: Test batch-to-batch consistency using standardized samples to ensure reliable experimental outcomes.

A properly validated antibody should yield consistent results with minimal background and non-specific binding across multiple experiments.

How should YGR164W antibodies be stored and handled to maintain optimal activity?

Based on protocols for similar yeast antibodies:

• Storage recommendations:

  • Store lyophilized antibodies at -20°C until reconstitution

  • After reconstitution, make small aliquots to avoid repeated freeze-thaw cycles

  • For long-term storage, maintain at -20°C or -80°C

• Handling practices:

  • Always spin tubes briefly before opening to collect all material

  • Reconstitute with sterile water or appropriate buffer as indicated in product documentation

  • Once thawed, keep antibody on ice during experiments

  • Avoid contamination by using clean pipette tips and sterile conditions

• Activity preservation:

  • Document lot number and date of reconstitution

  • Validate activity of older aliquots against fresh controls periodically

  • Use appropriate preservatives if recommended by manufacturer

Following these guidelines will help maintain antibody performance over time, similar to practices for RFA antibodies which are typically reconstituted with 50 μl of sterile water and stored at -20°C in aliquots .

What are the recommended protocols for using YGR164W antibodies in Western blotting?

Based on protocols for similar yeast protein antibodies:

Western Blot Protocol for Yeast Proteins:

• Sample preparation:

  • Prepare protein extracts using TCA precipitation method for best results with yeast samples

  • Include wild-type control and, if available, YGR164W deletion strain as negative control

• Gel electrophoresis:

  • Use 10% SDS-PAGE gels for optimal separation

  • Load 20-50 μg total protein per lane

• Transfer conditions:

  • Transfer to PVDF membrane (preferred over nitrocellulose for yeast proteins)

  • Use semi-dry or wet transfer systems at 100V for 1 hour or 30V overnight

• Blocking:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Antibody incubation:

  • Primary antibody: Test different dilutions (1:5000, 1:10,000, 1:20,000) to determine optimal signal-to-noise ratio

  • Incubate overnight at 4°C with gentle agitation

  • Secondary antibody: Use 1:10,000 dilution of appropriate HRP-conjugated secondary antibody

• Detection:

  • Visualize using ECL substrate

  • For weak signals, consider using enhanced sensitivity substrates

• Troubleshooting:

  • If non-specific bands appear (as observed with RFA antibodies at ~150 kDa), adjust blocking conditions or antibody dilutions

  • For clean detection of yeast proteins, freshly prepared samples yield better results than stored extracts

How can YGR164W antibodies be effectively used in chromatin immunoprecipitation (ChIP) assays?

ChIP Protocol Optimization for Yeast Protein Antibodies:

• Crosslinking and chromatin preparation:

  • For yeast cells, use 1% formaldehyde for 15-20 minutes at room temperature

  • Quench with 125 mM glycine for 5 minutes

  • Lyse cells using glass beads in a bead beater for efficient breakage of yeast cell walls

  • Sonicate to achieve chromatin fragments of 200-500 bp (verify by gel electrophoresis)

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Use 1:20,000 dilution for antibody incubation based on RFA antibody recommendations

  • Incubate overnight at 4°C with rotation

  • Include appropriate controls: IgG negative control and, if possible, a known target as positive control

• Washing and elution:

  • Perform stringent washes to reduce background

  • Elute DNA-protein complexes and reverse crosslinks at 65°C overnight

  • Treat with RNase A and Proteinase K before DNA purification

• Analysis:

  • Perform qPCR for known or suspected binding sites

  • For genome-wide studies, prepare libraries for ChIP-seq analysis

• Validation:

  • Confirm enrichment using qPCR before proceeding to sequencing

  • Use biological replicates to ensure reproducibility

This protocol has been successfully applied with RFA antibodies in studies exploring the relocation of transcribed genes to nuclear pore complexes, as cited in the Shi et al. (2023) publication .

What approaches can resolve common issues with non-specific binding in YGR164W antibody applications?

Non-specific binding is a common challenge with yeast protein antibodies. Here are methodological approaches to resolve these issues:

• Antibody titration optimization:

  • Test multiple dilutions to identify optimal concentration with highest signal-to-noise ratio

  • For Western blots, dilutions between 1:5000 and 1:20,000 are typically effective for yeast protein antibodies

• Blocking optimization:

  • Compare different blocking agents: non-fat milk, BSA, commercial blocking buffers

  • Test different concentrations (3-5%) and incubation times

  • For yeast proteins, adding 0.1% Tween-20 to blocking buffer often helps reduce background

• Sample preparation refinement:

  • For Western blotting, TCA precipitation of yeast proteins often yields cleaner results than other extraction methods

  • For immunoprecipitation, more stringent pre-clearing steps can reduce non-specific binding

• Cross-adsorption technique:

  • If available, incubate antibody with extract from YGR164W deletion strain to remove antibodies binding to non-specific epitopes

  • Remove antibody-bound proteins by precipitation before using in your experiment

• Wash buffer optimization:

  • Increase salt concentration in wash buffers incrementally (150 mM to 500 mM NaCl)

  • Add low concentrations of mild detergents (0.1-0.5% NP-40 or Triton X-100)

• Signal analysis:

  • Document any consistent non-specific bands (as seen with RFA antibodies at ~150 kDa)

  • Use appropriate molecular weight markers to distinguish specific from non-specific signals

How can YGR164W antibodies be used to study protein-protein interactions in yeast?

Methodological approaches for studying protein-protein interactions include:

• Co-immunoprecipitation (Co-IP):

  • Lyse yeast cells in non-denaturing buffers to maintain protein-protein interactions

  • Perform immunoprecipitation with YGR164W antibody

  • Analyze co-precipitated proteins by:

    • Western blotting for known/suspected interactors

    • Mass spectrometry for unbiased identification of interaction partners

  • Include appropriate controls: IgG control, deletion strain control

• Proximity-dependent labeling:

  • Generate fusion proteins (YGR164W-BirA) for BioID or similar approaches

  • Use YGR164W antibodies to verify expression and localization of fusion proteins

  • Identify proximal proteins through streptavidin pulldown and mass spectrometry

• Chromatin interaction studies:

  • For DNA-binding proteins, combine ChIP with YGR164W antibodies and Re-ChIP with antibodies against suspected interaction partners

  • This approach can identify proteins that co-occupy genomic regions

• Validation techniques:

  • Confirm interactions using reciprocal Co-IP

  • Perform genetic interaction studies (synthetic lethality, suppressor screens)

  • Use fluorescence microscopy to confirm co-localization

These approaches have been successfully employed with antibodies against yeast replication factors like RFA to study protein complexes involved in DNA replication and repair .

What considerations are important when using YGR164W antibodies for analyzing post-translational modifications?

Analysis of post-translational modifications (PTMs) requires specific methodological approaches:

• Detection strategies:

  • Primary approach: Use YGR164W antibody for immunoprecipitation followed by Western blotting with PTM-specific antibodies (phospho, ubiquitin, SUMO, etc.)

  • Alternative approach: Perform IP with PTM-specific antibodies and probe with YGR164W antibody

• Sample preparation considerations:

  • Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride) for phosphorylation studies

  • Add deubiquitinase inhibitors (N-ethylmaleimide) for ubiquitination analysis

  • Use fresh samples as PTMs can be labile during storage

• Analytical techniques:

  • Mass spectrometry analysis after IP for unbiased PTM identification

  • 2D gel electrophoresis to separate modified forms

  • Phos-tag gels for improved separation of phosphorylated proteins

• Validation methods:

  • Treatment with specific enzymes (phosphatases, deubiquitinases) to confirm PTM identity

  • Mutational analysis of modified residues

  • Correlation with cellular conditions known to induce specific modifications

• Experimental design table for PTM analysis:

How can researchers develop quantitative assays using YGR164W antibodies for measuring protein expression levels across different yeast strains or conditions?

Developing robust quantitative assays requires careful methodological planning:

• Western blot quantification protocol:

  • Use recombinant protein standards at known concentrations for calibration curve

  • Ensure samples are within linear range of detection

  • Implement technical replicates (minimum triplicate)

  • Use total protein normalization (stain-free technology or reversible total protein stains) rather than single housekeeping proteins

  • Analyze using appropriate software (ImageJ, Image Lab, etc.) with background subtraction

• ELISA development:

  • Coat plates with capture antibody (anti-YGR164W or an antibody against a tagged version)

  • Develop standard curve using purified recombinant protein

  • Optimize sample dilutions to fall within linear range

  • Use HRP-conjugated detection antibody and appropriate substrate

• Quantitative multiplexed assays:

  • Adapt to Luminex or similar bead-based platforms for higher throughput

  • Allows simultaneous quantification of multiple proteins in the same sample

  • Requires careful antibody labeling and validation

• Absolute quantification approaches:

  • Implement selective reaction monitoring (SRM) or parallel reaction monitoring (PRM) mass spectrometry

  • Use stable isotope-labeled peptide standards corresponding to unique YGR164W peptides

  • Can provide absolute quantification without antibody-based detection

• Data analysis and statistical considerations:

  • Use appropriate statistical tests based on data distribution

  • Account for batch effects in experimental design

  • Include biological replicates (minimum triplicate)

  • Document all normalization approaches transparently

• Quantitative experimental design examples:

How can YGR164W antibodies contribute to understanding human disease models involving homologous proteins?

While YGR164W is a yeast protein, studies of yeast proteins often provide insights into human disease through evolutionary conservation:

• Comparative analysis approaches:

  • Identify human homologs through sequence and structural analysis

  • Test cross-reactivity of YGR164W antibodies with human homologs

  • Use yeast as a model system to study mutations corresponding to human disease variants

• Disease modeling methodologies:

  • "Humanized yeast" approaches where human disease genes replace yeast counterparts

  • Study of fundamental processes conserved between yeast and humans

  • Investigation of pathways relevant to diseases like cancer where replication and repair proteins play key roles

• Potential applications in autoimmune research:

  • The study of Anti-Saccharomyces cerevisiae antibodies (ASCAs) in human diseases like Crohn's disease shows important connections between yeast immunology and human autoimmune conditions

  • Understanding the specific yeast epitopes recognized by human antibodies could inform therapeutic approaches

• Translational research framework:

  • Initial characterization in yeast models

  • Validation in human cell lines

  • Testing in animal models

  • Development of therapeutic applications

If YGR164W has homology to human proteins involved in disease processes, antibodies against it could provide valuable tools for understanding fundamental mechanisms conserved across species.

What novel microscopy techniques can be combined with YGR164W antibodies for advanced cellular localization studies?

Advanced microscopy applications with yeast protein antibodies include:

• Super-resolution microscopy protocols:

  • STORM (Stochastic Optical Reconstruction Microscopy):

    • Use directly-labeled primary antibodies for best resolution

    • Optimize buffer conditions for yeast cells (oxygen scavenging system with glucose oxidase)

    • Resolution potential: 20-30 nm

  • STED (Stimulated Emission Depletion):

    • Requires specific fluorophore-conjugated antibodies

    • Lower photobleaching compared to STORM

    • Resolution potential: 30-50 nm

• Live-cell imaging approaches:

  • Development of intrabodies (intracellular antibodies) derived from YGR164W antibodies

  • Nanobody development and fluorophore conjugation

  • Cell-penetrating peptide conjugation for antibody delivery into living yeast

• Correlative light and electron microscopy (CLEM):

  • Immunogold labeling with YGR164W antibodies

  • Precise localization at ultrastructural level

  • Protocol considerations for yeast cell wall permeabilization

• Proximity labeling techniques:

  • APEX2 or HRP conjugation to antibodies for spatial proteomics

  • BioID or TurboID approaches for neighbor protein identification

  • Requires validation of enzymatic activity post-conjugation

• Methodology comparison table:

How can researchers integrate YGR164W antibody data with genomics and proteomics approaches for systems biology studies?

Integration of antibody-based data with -omics approaches requires sophisticated methodological strategies:

• ChIP-seq integration framework:

  • Use YGR164W antibodies for chromatin immunoprecipitation followed by sequencing

  • Integrate binding profiles with:

    • Transcriptomics data (RNA-seq) to correlate binding with expression

    • Chromatin accessibility data (ATAC-seq)

    • Histone modification profiles

  • Analysis tools: MACS2 for peak calling, diffBind for differential binding analysis

• Proteomics integration approaches:

  • Combine IP-mass spectrometry data with:

    • Whole proteome studies

    • Protein-protein interaction networks

    • Post-translational modification maps

  • Analysis through protein correlation profiling

• Multi-omics data integration methodology:

  • Data normalization and batch effect correction

  • Dimensionality reduction techniques (PCA, t-SNE)

  • Network analysis and visualization (Cytoscape)

  • Pathway enrichment analysis (GO, KEGG)

• Yeast-specific databases and resources:

  • SGD (Saccharomyces Genome Database) for gene annotation

  • Integration with existing yeast interactome data

  • Comparative analysis with other model organisms

• Statistical approaches for integrative analysis:

  • Bayesian network modeling

  • Machine learning for pattern recognition

  • Multivariate statistical methods

• Visualizing multi-dimensional data:

  • Circos plots for genomic data integration

  • Heatmaps for expression correlation

  • Network diagrams for protein interactions

  • Genome browser tracks for ChIP-seq integration

This integrated approach allows researchers to place YGR164W in the broader context of cellular systems, understanding not just its function in isolation but its role within complex networks of interactions.

What are the best practices for using YGR164W antibodies in flow cytometry applications with yeast cells?

Flow cytometry with yeast cells presents unique challenges that require specialized protocols:

• Cell preparation methodology:

  • Fix cells with 3.7% formaldehyde for 30 minutes at room temperature

  • Permeabilize cell wall with zymolyase treatment (optimize concentration and time)

  • Alternative: 70% ethanol fixation overnight at 4°C provides good permeabilization

• Antibody staining protocol:

  • Block with 1% BSA in PBS for 30 minutes

  • Incubate with primary antibody at optimized concentration (typically start with 1:100-1:500 dilution)

  • Use fluorophore-conjugated secondary antibody appropriate for flow cytometer configuration

  • Include compensation controls if performing multi-color analysis

• Controls and validation:

  • Negative control: YGR164W deletion strain

  • Isotype control: Rabbit IgG at same concentration as primary antibody

  • Single-color controls for compensation

  • Fluorescence-minus-one (FMO) controls

• Data analysis considerations:

  • Gating strategy to exclude cell debris and doublets

  • Correlation with cell cycle markers if relevant

  • Analysis of signal intensity across different physiological conditions

• Troubleshooting yeast-specific issues:

  • High autofluorescence: Use fluorophores with emission spectra away from yeast autofluorescence

  • Cell aggregation: Add 0.1% Triton X-100 to reduce clumping

  • Variable permeabilization: Monitor with propidium iodide to ensure consistent access to intracellular targets

This application allows quantitative analysis of YGR164W protein levels at the single-cell level, revealing population heterogeneity that might be missed in bulk assays.